O
Outer Biosciences
Health · Palo Alto, United States · Founded 2020
AI-driven bioactive discovery using long-lasting skin models. MoreLess
Outer Biosciences, also known as Outer Bio, is a biotechnology research company that develops novel bioactive compounds for the health and beauty industries. Founded in 2020 by a team including CEO Michael Polansky, Chief Scientist Kyung-Jin Jang, CTO Chris Hinojosa, and Chief Business Officer Stanley King, the company operates at the intersection of biology, artificial intelligence, and dermatology. Entertainer and entrepreneur Stefani Germanotta (Lady Gaga) also co-founded the company and serves on its board of directors. The company's core technology is its proprietary "Yuna" platform, which maintains full-thickness human skin tissue, sourced ethically from surgical discards, viable in a lab for up to a month. This extended timeframe allows researchers to observe complex biological processes such as collagen remodeling, pigmentation changes, and skin barrier repair, which are not observable in conventional, shorter-duration lab models. Outer Biosciences couples these advanced ex vivo skin models with an AI and machine learning platform. The AI models screen millions of compounds to predict which bioactives may safely produce desired results, and these predictions are then tested on the living skin samples. The resulting data, whether the test is successful or not, is fed back into the system, creating a powerful feedback loop that continually refines future predictions. The firm's business model is not to create a consumer-facing brand, but to operate as a research and development engine for the broader cosmetics and pharmaceutical industries. It aims to license or sell its validated, high-efficacy ingredients to other companies, which will then incorporate them into final products like serums and creams. One of its known partners is Lady Gaga's cosmetics brand, Haus Labs. As of late 2026, the company, based near Cambridge, Massachusetts, has raised approximately $23 million in funding from investors including Wing Venture Capital, Initialized Capital, and Sozo Ventures to scale its operations. Keywords: bioactive discovery, skin health, ex vivo skin models, artificial intelligence, machine learning, dermatology, cosmetics ingredients, tissue engineering, multimodal data analysis, preclinical development, Yuna platform, Michael Polansky, Lady Gaga, natural compounds, skincare research, organotypic models, high-throughput screening, computational biology, drug discovery, beauty technology, biotechnology
Company overview
Outer Biosciences company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2020
- Headquarters
- Palo Alto, United States
- Employees
- 24
- Open positions
- None listed
- Dealroom signal
- 90.4
Valuation & funding
Outer Biosciences funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Aug 2026 | $19M | $76M | Undisclosed | ↗ |
| EARLY VC✓Equity / VC | Apr 2022 | $4M | $16M | Undisclosed | ↗ |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 24 |
| 2025 | 19 |
| 2024 | 11 |
Growth signals
Outer Biosciences website traffic
Latest recorded traffic for Outer Biosciences is 1.3K monthly website visits, down 18.8% over the last three months. Outer Biosciences's team grew 26.3% over the past year.
Comparisons
Outer Biosciences compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Outer Biosciences's talent
Source: Dealroom Talent Intelligence.
Investors
2 investors on Outer Biosciences's cap table
Sourced from Dealroom's funding and investor records.


Global footprint
Where Outer Biosciences has talent and traffic
team presence
In the news
Latest news about Outer Biosciences
Recent press, funding announcements, and product moves mentioning Outer Biosciences — open to read from the original sources.
Market sentiment
What the market is saying about Outer Biosciences
An AI-synthesized read of the highest-engagement posts about Outer Biosciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Outer Biosciences’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







